Cilioretinal Arteries and Cilioretinal Veins in Eyes with Pathologic Myopia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 02 2019
Historique:
received: 05 07 2018
accepted: 04 01 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 29 8 2020
Statut: epublish

Résumé

We investigated the clinical characteristics of cilioretinal arteries (CAs) and cilioretinal veins (CVs) in eyes with pathologic myopia. Ninety-five eyes with pathologic myopia and CAs were studied. The retrobulbar vessels from which the CAs originated were identified by indocyanine green angiography (ICGA). The results showed that 114 CAs were identified in the 95 eyes. ICGA showed that 60% of the CAs branched directly off the short posterior ciliary arteries (SPCAs) and 40% originated from the Zinn-Haller arterial circle (ZHAC). The SPCA-derived CAs tended to be located superiorly and served a large retinal area whereas the ZHAC-associated CAs tended to be located temporally and served mainly the macular area. In 15% of the 95 eyes, the CVs were observed to run parallel to the CAs. The CVs exited the eye at the same point where the CAs entered the eye. This study showed that CAs in eyes with pathologic myopia can be divided into those that are SPCA-derived and tend to emerge in the superior optic disc sector, and those that are ZHAC-associated and usually emerge temporally. An elongating peripapillary scleral flange in eyes with progressive axial myopia may lead to a change of chorioretinal vascular system.

Identifiants

pubmed: 30792400
doi: 10.1038/s41598-019-38616-5
pii: 10.1038/s41598-019-38616-5
pmc: PMC6384956
doi:

Substances chimiques

Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2451

Références

J Fr Ophtalmol. 1999 Apr;22(3):310-4
pubmed: 10337586
Trans Am Ophthalmol Soc. 1998;96:95-106; discussion 106-9
pubmed: 10360284
Jpn J Ophthalmol. 2000 May-Jun;44(3):312-3
pubmed: 10913654
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):170-4
pubmed: 12506071
Bull Soc Ophtalmol Fr. 1957 Nov;(9):598-601
pubmed: 13523344
Eye (Lond). 2005 Nov;19(11):1239-40
pubmed: 15543176
Curr Opin Ophthalmol. 2005 Apr;16(2):84-8
pubmed: 15744137
Ophthalmologica. 1992;204(3):115-21
pubmed: 1630760
Clin Anat. 2006 Oct;19(7):645-7
pubmed: 16795026
Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1113-22
pubmed: 21638030
Am J Ophthalmol. 2011 Dec;152(6):1021-9
pubmed: 21821229
Ophthalmology. 2012 Jan;119(1):21-6.e1-3
pubmed: 21978594
Can J Ophthalmol. 1990 Oct;25(6):298-300
pubmed: 2249166
Ophthalmology. 2012 Aug;119(8):1685-92
pubmed: 22494632
Int J Ophthalmol. 2011;4(3):323-5
pubmed: 22553672
Invest Ophthalmol Vis Sci. 2012 Oct 19;53(11):7290-8
pubmed: 23033385
PLoS One. 2012;7(10):e47237
pubmed: 23094040
Am J Ophthalmol. 2013 May;155(5):920-6
pubmed: 23394908
Invest Ophthalmol Vis Sci. 2013 Nov 25;54(12):7769-78
pubmed: 24168988
PLoS One. 2015 Oct 01;10(10):e0138825
pubmed: 26425846
Retina. 2017 Feb;37(2):299-304
pubmed: 27429391
Ophthalmology. 2018 Jun;125(6):863-877
pubmed: 29371011
J Clin Neuroophthalmol. 1986 Mar;6(1):1-10
pubmed: 2939105
Arch Ophthalmol. 1988 Dec;106(12):1691-3
pubmed: 3196210
Graefes Arch Clin Exp Ophthalmol. 1988;226(6):587-90
pubmed: 3209086
Ophthalmology. 1985 Jul;92(7):880-3
pubmed: 4022572
Arch Ophthalmol. 1977 Jul;95(7):1197-202
pubmed: 880079
Retina. 1996;16(5):419-25
pubmed: 8912969
Am J Ophthalmol. 1997 Apr;123(4):494-505
pubmed: 9124246
Arch Ophthalmol. 1976 Aug;94(8):1355-8
pubmed: 949278
Am J Ophthalmol. 1998 Jul;126(1):91-9
pubmed: 9683154
Br J Ophthalmol. 1998 Dec;82(12):1357-62
pubmed: 9930263

Auteurs

Takashi Watanabe (T)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Ophthalmology, Tokyo Metropolitan Health and Medical Treatment Corporation Tama-Nanbu Chiiki Hospital, Tokyo, Japan.

Kaori Kasahara (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Soh Futagami (S)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Ophthalmology, Nissan Tamagawa Hospital, Tokyo, Japan.

Yuxin Fang (Y)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Ran Du (R)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Muka Moriyama (M)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Kengo Uramoto (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Tae Yokoi (T)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Yuka Onishi (Y)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Takeshi Yoshida (T)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Koju Kamoi (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Jost B Jonas (JB)

Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Seegartenklinik Heidelberg, Germany.

Kyoko Ohno-Matsui (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan. k.ohno.oph@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH